Incretin-Based Therapies—Semaglutide, Tirzepatide, and Sitagliptin: Evaluating Pancreatitis Risk in Type 2 Diabetes Mellitus
Authors: Perez, Sui-Ling, Hernandez Suarez, Enmanuel, Perez-Lago, Gabriella et al.
Publication:
Published: Unknown date
Source: Crossref